Also trades as: HOFBF (OTC) · $vol 0M
HBC.OL OSL
Hofseth BioCare ASA
1W: -5.7%
1M: -3.6%
3M: -11.3%
YTD: -1.5%
1Y: -30.0%
3Y: -56.2%
5Y: -82.0%
kr 1.33 ($0.14)
+0.03 (+2.31%)
Weekly Expected Move ±9.1%
kr 1
kr 1
kr 1
kr 1
kr 2
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Balance Sheet Trends
Total Assets
$394M
+15.5% ▲
5Y CAGR: -3.0%
Total Liabilities
$470M
+67.7% ▲
5Y CAGR: +19.2%
Shareholders Equity
-$75M
-224.6% ▼
Cash & Investments
$67M
+162.1% ▲
5Y CAGR: -17.0%
Total Debt
$301M
+76.0% ▲
5Y CAGR: +24.4%
Net Debt
$234M
+60.9% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $47M | $30M | $24M | $26M | $67M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $47M | $30M | $24M | $26M | $67M |
| Net Receivables | $22M | $14M | $15M | $21M | $22M |
| Inventory | $91M | $117M | $83M | $56M | $60M |
| Other Current Assets | $18M | $11M | $7M | $5M | $13M |
| Total Current Assets | $170M | $176M | $131M | $112M | $162M |
| Property, Plant & Equip. | $186M | $169M | $166M | $138M | $147M |
| Goodwill & Intangibles | $53M | $61M | $55M | $42M | $36M |
| Long-Term Investments | $7M | $7M | $38M | $47M | $49M |
| Other Non-Current Assets | $7M | $6M | $439K | $2M | $0 |
| Total Non-Current Assets | $246M | $235M | $259M | $229M | $232M |
| Total Assets | $416M | $411M | $390M | $341M | $394M |
| — Liabilities — | |||||
| Accounts Payable | $124M | $146M | $55M | $94M | $95M |
| Short-Term Debt | $2M | $540K | $173M | $48M | $72M |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $0 | $0 | $8M | $1K | $74M |
| Total Current Liabilities | $151M | $172M | $252M | $168M | $241M |
| Long-Term Debt | $24M | $812K | $271K | $25M | $229M |
| Other Non-Current Liab. | -$1K | $0 | $0 | $0 | $0 |
| Total Non-Current Liabilities | $125M | $91M | $97M | $112M | $229M |
| Total Liabilities | $276M | $263M | $349M | $280M | $470M |
| — Equity — | |||||
| Common Stock | $4M | $4M | $4M | $4M | $4M |
| Retained Earnings | $0 | $146M | $0 | $0 | -$79M |
| Accumulated OCI | $0 | $0 | $0 | $0 | $0 |
| Total Stockholders Equity | $141M | $149M | $42M | $60M | -$75M |
| Total Liabilities & Equity | $416M | $411M | $390M | $341M | $394M |
| — Key Metrics — | |||||
| Total Debt | $139M | $104M | $281M | $171M | $301M |
| Net Debt | $92M | $74M | $260M | $145M | $234M |
| Total Investments | $7M | $7M | $38M | $47M | $49M |